Spartin/SPG20 Rekombinanter Antikörper
Spartin/SPG20 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250440A11
Kat-Nr. : 85938-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
85938-2-PBS bindet in WB, Indirect ELISA Spartin/SPG20 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Spartin/SPG20 fusion protein Ag4815 |
| Vollständiger Name | spastic paraplegia 20 (Troyer syndrome) |
| Berechnetes Molekulargewicht | 72 kDa |
| Beobachtetes Molekulargewicht | 75-84 kDa |
| GenBank-Zugangsnummer | BC047083 |
| Gene symbol | Spartin |
| Gene ID (NCBI) | 23111 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
SPG20 (spastic paraplegia 20) gene encodes a multifunctional Spartin protein. SPG20 protein is highly expressed in adipose tissue and may be implicated in endosomal trafficking and microtubule dynamics. SPG20 is mutated in Troyer syndrome, a hereditary spastic paraplegia defined by degeneration of upper motor neurons, recent study showed that regulation of SPG20 on mitochondrial calcium homeostasis may contribute to the pathophysiology of Troyer syndrome. Hypermethylation of SPG20 promoter, found in colorectal cancer patients, may play a role in cytokinesis arrest in colorectal tumorigenesis.



